𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Selegiline and cognitive function in Parkinson's disease

✍ Scribed by M. H. Hietanen

Book ID
114783503
Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
308 KB
Volume
84
Category
Article
ISSN
0001-6314

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Selegiline in Parkinson's disease
Selegiline in Parkinson's disease
✍ H. TerΓ€vΓ€inen πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 430 KB
Selegiline and mortality in Parkinson's
Selegiline and mortality in Parkinson's disease
✍ Dr. C. W. Olanow; S. Fahn; J. W. Langston; J. Godbold πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 489 KB πŸ‘ 2 views

## Do Other Studies Show Increased Mortality Due to Selegiline? Other than the UK study, no clinical trial to date has shown an increase in mortality in association with the use of selegiline. In the Sindepar study, a cohort of I01 untreated P D patients participated in a 14-month prospective, ran

Smoking and cognitive function in Parkin
Smoking and cognitive function in Parkinson's disease
✍ Marc G. Weisskopf; Francine Grodstein; Alberto Ascherio πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 98 KB πŸ‘ 1 views

## Abstract The risk of dementia among Parkinson's disease (PD) patients is greatly elevated compared to controls, yet little is known about determinants of cognitive function among PD patients. We assessed the relation between cigarette smoking prior to disease onset and later cognitive function a

Parkinson's disease/Parkinson syndromesβ€”
Parkinson's disease/Parkinson syndromesβ€”Cognitive functions
πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 289 KB

We have measured increment thresholds for a 4.1 cycfdeg grating in 24 de-novo patients (Hoehn and Yahr stage I to 111) with idiopathic (IPS) and 9 patients with nonidiopathic parkinson syndrome (N-IPS) and for comparison 26 age-matched normal controls. Patients with positive L-Dopa and apomorphine